Company Filing History:
Years Active: 2012
Title: Innovations by Inventor Christian Lerner from Binningen, CH
Introduction
Christian Lerner is a notable inventor based in Binningen, Switzerland, who has made significant contributions to the field of pharmaceutical compounds, particularly focusing on glucocorticoid receptor antagonists. With two patents to his name, Lerner's work reflects a commitment to advancing medical treatments for various health issues.
Latest Patents
Lerner's latest innovations include two critical patents that address significant health concerns. The first patent, titled "2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds," describes compounds that function as glucocorticoid receptor antagonists. These compounds have the potential to treat or prevent several diseases, including diabetes, dyslipidemia, obesity, hypertension, cardiovascular diseases, adrenal imbalance, and depression. The second patent, "Substituted benzene compounds as modulators of the glucocorticoid receptor," further enhances this area of research, detailing additional compounds that also serve as antagonists for the glucocorticoid receptor, broadening the scope of potential treatments.
Career Highlights
Christian Lerner currently works at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry, where he has been able to focus on his passion for innovation and invention. His work significantly contributes to the development of new therapeutic solutions to improve the health and well-being of patients worldwide.
Collaborations
Throughout his career, Lerner has collaborated with talented colleagues, including Daniel Hunziker and Werner Mueller. These partnerships foster a creative environment that encourages groundbreaking research and the development of new medicinal compounds.
Conclusion
Christian Lerner is an inspiring inventor whose work on glucocorticoid receptor antagonists has the potential to make a meaningful impact on modern medicine. His patents highlight a dedication to finding innovative solutions to complex health challenges, positioning him as a significant contributor to the pharmaceutical field.